Skip to main content
Advertisement
Advertisement
RMD
RMD logo
ResMed Inc.
229.94
USD
Sponsored
-22.89
-9.05%
Oct 30, 16:00 UTC -4
Closed
exchange

After-Market

230.25

+0.31
+0.14%

ResMed Inc. (RMD) Earnings

RMD Earnings Reports

Positive Surprise Ratio

RMD beat 30 of 43 last estimates.

70%

Next Report

Date of Next Report
Jan 27, 2027
Estimate for Q2 27 (Revenue/ EPS)
$1.47B
/
$3.05
Implied change from Q1 27 (Revenue/ EPS)
+3.75%
/
+4.81%
Implied change from Q2 26 (Revenue/ EPS)
+0.29%
/
+8.54%

ResMed Inc. earnings per share and revenue

On Oct 29, 2026, RMD reported earnings of 2.91 USD per share (EPS) for Q1 27, beating the estimate of 2.69 USD, resulting in a 7.79% surprise. Revenue reached 1.41 billion, compared to an expected 1.41 billion, with a 0.63% difference.
Looking ahead to Q2 27, -- analysts forecast an EPS of 3.05 USD, with revenue projected to reach 1.47 billion USD, implying an increase of 4.81% EPS, and increase of 3.75% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Abbott Laboratories
Report Date
Oct 21, 2026 For Q3 26
Estimate
$1.42
Actual
$1.42
Surprise
-0.68%
logo
Stryker Corporation
Report Date
Oct 29, 2026 For Q3 26
Estimate
$3.58
Actual
$3.52
Surprise
-1.75%
logo
Boston Scientific Corp.
Report Date
Oct 28, 2026 For Q3 26
Estimate
$0.72
Actual
$0.73
Surprise
+1.05%
logo
GE HealthCare Technologies Inc. Common Stock
Report Date
Oct 28, 2026 For Q3 26
Estimate
$1.22
Actual
$1.34
Surprise
+9.13%
logo
Baxter International Inc.
Report Date
Oct 29, 2026 For Q3 26
Estimate
$0.52
Actual
$0.57
Surprise
+10.86%
logo
Sundial Growers Inc. Common Shares
Report Date
Oct 27, 2026 For Q3 26
Estimate
-$0.02
Actual
-$0.04
Surprise
-101.26%
FAQ
For Q1 2027, ResMed Inc. reported EPS of $2.91, beating estimates by 7.79%, and revenue of $1.41B, 0.63% above expectations.
The stock price moved -- --, changed from -- before the earnings release to -- the day after.
The next earning report is scheduled for Jan 27, 2027.
Based on -- analysts, ResMed Inc. is expected to report EPS of $3.05 and revenue of $1.47B for Q2 2027.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement